Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThe documents posted on Zyprexa.pbwiki.com were the basis of recent stories in The New York Times suggesting the Indianapolis drug maker downplayed weight gain and other side effects of the blockbuster, according to The Register, a British publication focused on the information technology industry.
Lilly has spent about $1.2 billion to settle class-action lawsuits filed by Zyprexa patients.
Please enable JavaScript to view this content.